Valuation: AcouSort AB

Market Cap 63.07M 6.39M 5.58M 5.27M 4.78M 8.96M 614M 9M 24.34M 312M 24.02M 23.49M 1B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 63.07M 6.39M 5.58M 5.27M 4.78M 8.96M 614M 9M 24.34M 312M 24.02M 23.49M 1B EV / Sales 2026 *
6.37x
EV / Sales 2027 * 4.26x
Free-Float
70.68%
Yield 2026 *
-
Yield 2027 * -
1 day+7.97%
1 week+4.93%
Current month-1.65%
1 month-5.70%
3 months-28.71%
6 months-6.29%
Current year+5.30%
1 week 2.59
Extreme 2.59
2.98
1 month 2.5
Extreme 2.5
3.49
Current year 2.03
Extreme 2.03
5.16
1 year 2.03
Extreme 2.03
5.16
3 years 2.03
Extreme 2.03
28.6
5 years 2.03
Extreme 2.03
32.95
10 years 2.03
Extreme 2.03
32.95
Manager TitleAgeSince
Chief Executive Officer 68 31/12/2013
Director of Finance/CFO 65 31/12/2015
Director TitleAgeSince
Director/Board Member 64 31/12/2011
Chairman 65 31/12/2010
Director/Board Member - 30/11/2021
Change 5-day change 1-year change 3-year change Capi.($)
+7.97%+4.93%-8.02%-88.17% 6.39M
+0.11%+2.71%+0.33%+28.59% 46.28B
-1.12%+1.78%+40.07%+27.26% 43.85B
-3.04%-6.29%+322.27%+517.36% 40.93B
-0.74%+1.25%+2.32%+67.94% 39.9B
-0.50%+0.67%+11.79%+40.51% 29.5B
-0.46%+4.22%+21.99%+124.21% 17.09B
-0.97%-10.17% - - 15.55B
-0.57%+8.12%+22.15%+38.93% 15.22B
-3.14%+31.91%-10.60% - 14.05B
Average -0.10%+3.88%+44.70%+94.58% 26.24B
Weighted average by Cap. -1.02%+1.87%+64.69%+130.23%

Financials

2026 *2027 *
Net sales 9.9M 1M 875K 826K 751K 1.41M 96.32M 1.41M 3.82M 48.97M 3.77M 3.69M 158M 14.8M 1.5M 1.31M 1.24M 1.12M 2.1M 144M 2.11M 5.71M 73.21M 5.64M 5.51M 236M
Net income - -
Net Debt - -
Logo AcouSort AB
Acousort AB is a Sweden-based company engaged in the medical technology. The Company develops, produces and sells standalone laboratory products and integrated original equipment manufacturer (OEM) solutions where ultrasound is used to separate, wash and enrich cells, exosomes and other biological particles for research and diagnostics. Its product portfolio includes AcouWash and AcouTrap that are targeting separation, washing and enrichment applications within cell, bacteria and extracellular vesicle research. In addition, the Company develops proprietary bioanalytical and clinical applications based on acoustophoresis, and offers custom-developed acoustophoresis applications.
Employees
11
Date Price Change Volume
18/09/26 SEK 2.980 +7.97% 21,344
17/09/26 SEK 2.760 +2.99% 16,274
16/09/26 SEK 2.680 +0.75% 3,390
15/09/26 SEK 2.660 -1.12% 19,704
14/09/26 SEK 2.690 -5.28% 5,937

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACOU Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!